Oragenics, Inc.
(NYSE Amex Equities : OGEN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.45%185.151.2%$602.67m
CELGCelgene Corporation
-0.43%78.801.2%$532.62m
GILDGilead Sciences, Inc.
-0.63%71.070.9%$518.63m
BIIBBiogen Inc.
-0.44%296.041.2%$437.32m
NKTRNektar Therapeutics
-5.39%52.855.6%$412.99m
SRPTSarepta Therapeutics, Inc.
-6.23%140.3316.6%$356.37m
VRTXVertex Pharmaceuticals Incorporated
1.67%159.191.9%$269.27m
REGNRegeneron Pharmaceuticals, Inc.
0.89%331.972.6%$248.01m
ILMNIllumina, Inc.
-1.19%282.653.5%$212.82m
BLUEBluebird Bio, Inc.
-9.85%168.9015.7%$194.29m
EXASExact Sciences Corporation
-3.62%66.3325.4%$180.98m
AAgilent Technologies, Inc.
-0.40%62.791.5%$178.44m
ALXNAlexion Pharmaceuticals, Inc.
1.40%127.572.0%$159.93m
BMRNBioMarin Pharmaceutical Inc.
0.61%99.034.4%$141.99m
INCYIncyte Corporation
2.12%74.032.5%$133.28m

Company Profile

Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of lantibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.